Skip to content
Sign in

HQH · NYSE · Closed-end fund

abrdn Healthcare Investors (HQH) Price, Holdings & Fees

$1,407.86−0.29%−$4.05End-of-day price as of Oct 9, 2026

abrdn Healthcare Investors (HQH) closed at $1,407.86 on Oct 9, 2026, down 0.29% from the previous close of $1,411.91.

Share price, past year

1Y +40.63%

52-week range $993.91 – $1,431.38. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$1,407.86
Sep 30, 2026$1,408.10
Aug 31, 2026$1,343.20
Jul 31, 2026$1,332.55
Jun 30, 2026$1,263.33
May 29, 2026$1,130.20
Apr 30, 2026$1,152.55
Mar 31, 2026$1,201.06
Feb 27, 2026$1,232.60
Jan 30, 2026$1,185.81
Dec 31, 2025$1,190.63
Nov 28, 2025$1,132.80
Oct 31, 2025$1,029.98

Key statistics

Expense ratio
—
Net assets
$1.4B
as of Jun 30, 2026
Holdings
167
as of Jun 30, 2026
52-week range
$993.91 – $1,431.38

Holdings

abrdn Healthcare Investors held 167 investments worth $1.36B as of Jun 30, 2026. Its largest holding was uniQure NV, at 4.19% of the fund.

abrdn Healthcare Investors largest holdings by share of net assets
#Holding% of fundValue
1uniQure NV4.19%$57.13M
2VeraDermics Inc3.41%$46.47M
3Insmed Inc2.80%$38.11M
4Argenx SE2.48%$33.84M
5VERADERMICS, INC.2.26%$30.72M
6Personalis Inc2.17%$29.54M
7Tectonic Therapeutic Inc1.95%$26.50M
8Oruka Therapeutics Inc1.91%$26.03M
9Abbott Laboratories1.83%$24.86M
10BioCryst Pharmaceuticals Inc1.71%$23.24M
11UnitedHealth Group Inc1.63%$22.20M
12Humana Inc1.62%$22.09M
13Denali Therapeutics Inc1.62%$22.05M
14Amgen Inc1.48%$20.21M
15Immunovant Inc1.47%$20.03M
16Abivax SA1.47%$20.01M
17Praxis Precision Medicines Inc1.46%$19.89M
18Crinetics Pharmaceuticals Inc1.40%$19.02M
19EyePoint Inc1.28%$17.46M
20Medtronic PLC1.22%$16.56M
21Danaher Corp1.21%$16.53M
22Intuitive Surgical Inc1.21%$16.44M
23Dyne Therapeutics Inc1.21%$16.43M
24NEUROVANCE MILESTONE INTEREST1.21%$16.42M
25Structure Therapeutics Inc1.19%$16.17M

Top 25 of 167 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.

What the fund owns

abrdn Healthcare Investors holdings by asset type
Asset type% of fund
Stocks88.06%
Preferred stock7.58%
Derivatives2.58%
Cash and short-term investments1.27%
Bonds and other debt0.42%
Other asset-backed securities0.11%
abrdn Healthcare Investors holdings by country, largest 10
Country% of fund
United States83.74%
Netherlands7.86%
Ireland2.76%
France1.47%
Canada1.38%
Cayman Islands1.19%
Switzerland0.74%
Belgium0.35%
Denmark0.33%
Singapore0.19%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to Jun 30, 2026, abrdn Healthcare Investors's total return was +27.33%, as reported to the SEC.

abrdn Healthcare Investors monthly total returns
MonthTotal return
Jun 30, 2026+9.95%
May 31, 2026+3.79%
Apr 30, 2026+11.58%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
abrdn Healthcare Investors
Ticker
HQH
Exchange
NYSE
Fund type
Closed-end fund
SEC CIK
0000805267
Fractional shares
Yes

Recent SEC filings

Frequently asked questions

What is HQH's price?

abrdn Healthcare Investors (HQH) closed at $1,407.86 on Oct 9, 2026, down 0.29% from the previous close of $1,411.91.

What does HQH hold?

abrdn Healthcare Investors held 167 investments worth $1.36B as of Jun 30, 2026. Its largest holding was uniQure NV, at 4.19% of the fund. Its five largest holdings were uniQure NV, VeraDermics Inc, Insmed Inc, Argenx SE, VERADERMICS, INC..

How has HQH performed?

Over the 3 months to Jun 30, 2026, abrdn Healthcare Investors's total return was +27.33%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 28, 2026). Prices are generated sample data for development. Data sources and disclosures